FDA also launched a dedicated webpage for telehealth companies that highlights common compliance pitfalls in promoting compounded drugs, alongside a separate webpage outlining the agencys specific concerns with compounded GLP1 products.[1] This follows an unusually active enforcement period in late 2025 and early 2026
Building tracking habits that persist through travel, illness, busy periods, and motivational dips requires designing the system around your actual life rather than an idealized version of it
The bottom line is: not all fragrances/parfum/ingredients are created equally
Under the Contract Year 2026 MA and Part D proposed rule (PDF), CMS is choosing to follow conventional medical thinking that obesity is a disease
While occasional night sweats may not warrant immediate concern, certain features should prompt medical evaluation
Appetite is back to baseline